P A Thompson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

P A Thompson

Showing results (121-130 of 122) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 122 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017

Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)P Jain, E Aoki, M Keating, et al.

Leukemia|October 4, 2017

Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathwayK Kondo, H Shaim, P A Thompson, et al.

Pageof 13

Search research articles

Showing results (121-130 of 122) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 122 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017

Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)P Jain, E Aoki, M Keating, et al.

Leukemia|October 4, 2017

Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathwayK Kondo, H Shaim, P A Thompson, et al.

Pageof 13